|
1.
|
Results of the $^{244}$Cm, $^{246}$Cm and $^{248}$Cm neutron-induced capture cross sections measurements at EAR1 and EAR2 of the n_TOF facility
/ nTOF Collaboration
Accurate neutron capture cross section data for minor actinides (MAs) are required to estimate the production and transmutation rates of MAs in light water reactors, critical fast reactors like Gen-IV systems, and other innovative reactor systems such as accelerator driven systems (ADS). In particular, 244Cm, 246Cm and 248Cm play a role in the transport, storage and transmutation of the nuclear waste of the current nuclear reactors, due to the contribution of these isotopes to the radiotoxicity, neutron emission, and decay heat in the spent nuclear fuel. [...]
2023 - 6 p.
- Published in : EPJ Web Conf. 284 (2023) 01009
Fulltext: PDF;
In : 15th International Conference on Nuclear Data for Science and Technology, Online, 21 - 29 Jul 2022, pp.01009
|
|
|
2.
|
Terbium-149 production: a focus on yield and quality improvement towards preclinical application
/ Favaretto, C (Basel U. ; PSI, Villigen) ; Grundler, P V (PSI, Villigen) ; Talip, Z (PSI, Villigen) ; Köster, U (Laue-Langevin Inst. ; CERN) ; Johnston, K (CERN) ; Busslinger, S D (PSI, Villigen) ; Sprung, P (PSI, Villigen) ; Hillhouse, C C (PSI, Villigen) ; Eichler, R (PSI, Villigen ; Bern U.) ; Schibli, R (PSI, Villigen ; Zurich, ETH) et al.
Terbium-149 (T$_{1/2}$ = 4.1 h, E$_{α}$ = 3.98 MeV (16.7%), 28 µm range in tissue) is a radionuclide with potential for targeted alpha therapy. Due to the negligible emission of α-emitting daughter nuclides, toxicity to healthy tissue may be reduced in comparison with other α-particle emitters. [...]
2024 - 12 p.
- Published in : Sci. Rep. 14 (2024) 3284
Fulltext: PDF;
|
|
|
3.
|
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
/ Radzina, Maija (Latvia U. ; CERN) ; Saule, Laura (Latvia U.) ; Mamis, Edgars (Latvia U. ; CERN) ; Koester, Ulli (Laue-Langevin Inst.) ; Cocolios, Thomas Elias (Leuven U.) ; Pajuste, Elina (Latvia U.) ; Kalnina, Marika (Unlisted) ; Palskis, Kristaps (CERN ; Riga Tech. U.) ; Sawitzki, Zoe (Leuven U.) ; Talip, Zeynep (PSI, Villigen) et al.
Background
In order to support the ongoing research across Europe to facilitate access to novel radionuclides, the PRISMAP consortium (European medical radionuclides programme) was established to offer the broadest catalog of non-conventional radionuclides for medical and translational research. The aim of this article is to introduce readers with current status of novel radionuclides in Europe.
Main body
A consortium questionnaire was disseminated through the PRISMAP consortium and user community, professional associations and preclinical/clinical end users in Europe and the current status of clinical end-users in nuclear medicine were identified. [...]
2023 - 16 p.
- Published in : EJNMMI Radiopharm. Chem. 8 (2023) 27
Fulltext: PDF;
|
|
|
4.
|
High-resolution cross section measurements for neutron interactions on $^{89}$Y with incident neutron energies up to 95 keV
/ Tagliente, G (INFN, Bari) ; Milazzo, P M (INFN, Trieste) ; Paradela, C (Geel, JRC) ; Kopecky, S (Geel, JRC) ; Vescovi, D (INFN, Perugia ; Cagliari Observ.) ; Alaerts, G (Geel, JRC) ; Damone, L A (INFN, Bari ; CERN) ; Heyse, J (Geel, JRC) ; Krtička, M (Charles U.) ; Schillebeeckx, P (Geel, JRC) et al.
The cross section of the $^{89}$Y(n, $\gamma $) reaction has important implications in nuclear astrophysics and for advanced nuclear technology. Given its neutron magic number N = 50 and a consequent small neutron capture cross section, $^{89}$Y represents one of the key nuclides for the stellar s-process. [...]
2024 - 18 p.
- Published in : Eur. Phys. J. A 60 (2024) 21
|
|
|
5.
|
|
|
Terbium-149 for targeted alpha therapy
/ Grundler, Pascal (Paul Scherrer Institut, Villigen – ETH Zürich, Switzerland) ; Johnston, Karl (CERN, ISOLDE) ; Koester, Ulli (Institut Laue-Langevin, Grenoble, France) ; Mueller, Cristina (Paul Scherrer Institut, Villigen – ETH Zürich, Switzerland) ; Talip, Zeynap (Paul Scherrer Institut, Villigen – ETH Zürich, Switzerland) ; van der Meulen, Nick (Paul Scherrer Institut, Villigen – ETH Zürich, Switzerland)
CERN-INTC-2023-025 ; INTC-P-593-ADD-1.
-
2023.
Fulltext - Original Document (INTC-P-593)
|
|
|
6.
|
|
|
7.
|
Characterization and First Test of an i-TED Prototype at CERN n_TOF
/ Babiano-Suarez, V (Valencia U., IFIC) ; Caballero, L (Valencia U., IFIC) ; Domingo-Pardo, C (Valencia U., IFIC) ; Ladarescu, I (Valencia U., IFIC) ; Aberle, O (CERN) ; Alcayne, V (Madrid, CIEMAT) ; Amaducci, S (INFN, Catania) ; Andrzejewski, J (Lodz U.) ; Audouin, L (Orsay, IPN) ; Bacak, M (CERN ; TU Vienna) et al.
Neutron capture cross section measurements are of fundamental importance for the study of the slow process of neutron capture, so called s-process. This mechanism is responsible for the formation of most elements heavier than iron in the Universe. [...]
2019 - 5 p.
- Published in : Springer Proc. Phys. 225 (2019) 169-173
In : La Rábida 2018 International Scientific Meeting on Nuclear Physics, La Rábida, Spain, 18 - 22 Jun 2018, pp.169-173
|
|
|
8.
|
Measurement of the $^{244}$ Cm and $^{246}$ Cm Neutron-Induced Cross Sections at the n_TOF Facility
/ Alcayne, V (Madrid, CIEMAT) ; Kimura, A (JAERI, Tokai) ; Mendoza, E (Madrid, CIEMAT) ; Cano-Ott, D (Madrid, CIEMAT) ; Aberle, O (CERN) ; Amaducci, S (INFN, Catania) ; Andrzejewski, J (Lodz U.) ; Audouin, L (Orsay, IPN) ; Babiano-Suarez, V (Valencia U., IFIC) ; Bacak, M (CERN ; Vienna, Tech. U.) et al.
The neutron capture reactions of the$^{244}$ Cm and$^{246}$ Cm isotopes open the path for the formation of heavier Cm isotopes and of heavier elements such as Bk and Cf in a nuclear reactor. In addition, both isotopes belong to the minor actinides with a large contribution to the decay heat and to the neutron emission in irradiated fuels proposed for the transmutation of nuclear waste and fast critical reactors. [...]
2019 - 6 p.
- Published in : Springer Proc. Phys. 225 (2019) 117-122
In : La Rábida 2018 International Scientific Meeting on Nuclear Physics, La Rábida, Spain, 18 - 22 Jun 2018, pp.117-122
|
|
|
9.
|
Efficient Production of High Specific Activity Thulium-167 at Paul Scherrer Institute and CERN-MEDICIS
/ Heinke, Reinhard (CERN ; Leuven U.) ; Chevallay, Eric (CERN) ; Chrysalidis, Katerina (CERN) ; Cocolios, Thomas E (Leuven U.) ; Duchemin, Charlotte (Leuven U. ; CERN) ; Fedosseev, Valentin N (CERN) ; Hurier, Sophie (Leuven U. ; SCK-CEN, Mol) ; Lambert, Laura (CERN) ; Leenders, Benji (Leuven U. ; SCK-CEN, Mol ; Gent U.) ; Marsh, Bruce A (CERN) et al.
Thulium-167 is a promising radionuclide for nuclear medicine applications with potential use for both diagnosis and therapy (“theragnostics”) in disseminated tumor cells and small metastases, due to suitable gamma-line as well as conversion/Auger electron energies. However, adequate delivery methods are yet to be developed and accompanying radiobiological effects to be investigated, demanding the availability of $^{167}$Tm in appropriate activities and quality. [...]
2021
- Published in : Frontiers in Medicine 8 (2021) 712374
Fulltext: PDF;
|
|
|
10.
|
CERN-MEDICIS: A Review Since Commissioning in 2017
/ MEDICIS Collaboration
The CERN-MEDICIS (MEDical Isotopes Collected from ISolde) facility has delivered its first radioactive ion beam at CERN (Switzerland) in December 2017 to support the research and development in nuclear medicine using non-conventional radionuclides. Since then, fourteen institutes, including CERN, have joined the collaboration to drive the scientific program of this unique installation and evaluate the needs of the community to improve the research in imaging, diagnostics, radiation therapy and personalized medicine. [...]
2021 - 11 p.
- Published in : Frontiers in Medicine 8 (2021) 693682
Fulltext: PDF;
|
|
email alert
or subscribe to the 
RSS feed.